HGEN Stock Price, News & Analysis

HGEN OTC

Company Description

HGEN (OTC: HGEN) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

HGEN stock has declined 99.9% over the past year.

This page provides a comprehensive overview of HGEN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-99.93%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

HGEN (HGEN) stock. Over the past 12 months, the stock has lost 99.9%.

Latest News

View All

August 7, 2023

+3.95%

Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation

June 9, 2023

+1.45%

Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress

August 12, 2022

+5.56%

Humanigen Reports Second Quarter 2022 Financial Results

earnings

July 13, 2022

-79.56%

Humanigen Receives Preliminary Topline Data From NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B

July 6, 2022

+14.36%

Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein

covid-19

June 30, 2022

-3.80%

NIH/NIAID Locks ACTIV-5/BET-B Database

HGEN has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, covid-19. View all HGEN news →

SEC Filings

View All

No SEC filings available for HGEN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

HGEN Company Profile & Sector Positioning

HGEN (HGEN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.